Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist. [electronic resource]
Producer: 20100624Description: 170-6 p. digitalISSN:- 1938-2723
- Acute Coronary Syndrome -- drug therapy
- Angioplasty, Balloon, Coronary
- Aspirin -- therapeutic use
- Clinical Trials, Phase III as Topic
- Clopidogrel
- Drug Evaluation, Preclinical
- Drug Therapy, Combination
- Hemorrhage -- chemically induced
- Humans
- Ischemia -- prevention & control
- Kidney Failure, Chronic -- metabolism
- Piperazines -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Prasugrel Hydrochloride
- Purinergic P2 Receptor Antagonists
- Randomized Controlled Trials as Topic
- Receptors, Purinergic P2Y12
- Thiophenes -- adverse effects
- Ticlopidine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.